Why BGPT?
logo

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review paper



    Explore by Goal












     Quick Explanation


    What this paper adds (and what it doesn’t)
    • Known from the paper: Rb–E2F-1 derepression is reported to directly upregulate transcription of PTP-1B (PTPN1), SHP-2 (PTPN11), and PTP-PEST (PTPN12) during a p53-independent apoptosis program (dnE2F1 ER model), supported by qPCR time course and E2F-1 ChIP.
    • Core mechanistic gap: The work proposes that these PTPs could act in concert to dephosphorylate/β€œinactivate” FAK, promoting the apoptosis pathway, but the provided text does not show direct functional necessity (e.g., PTP knockdown/rescue paired with FAK dephosphorylation and apoptosis quantification).



     Long Explanation


    Paper Review (Visual + Skeptical): SHP-2 and PTP-PEST induction during Rb-E2F associated apoptosis
    Primary source provided: Morales et al., 2012, DOI: 10.2478/s11658-012-0020-9
    Context: Rb–E2F-1 repression loss β†’ p53-independent apoptosis β†’ reported direct transcriptional activation of PTPN1/PTPN11/PTPN12.
    RB–E2F-1 β†’ PTP gene activation β†’ proposed apoptosis signaling
    Claim supported by data (in the provided text)
    • dnE2F1 induction is reported to produce rapid apoptosis (sub-G1 accumulation), interpreted as p53-independent.
    • PTPN1/PTPN11/PTPN12 mRNA increase within ~1.5 h and then decline toward baseline by 48 h (qPCR).
    • Direct regulation evidence: E2F-1 binding to promoter regions of these three PTP genes via ChIP is reported, with promoter binding assessed using TRANSFAC-predicted sites and E2F-1 antibody with negative controls (no Ab / no chromatin).
    Proposed but not functionally validated in provided text
    • The paper proposes these PTPs may act in concert to dephosphorylate FAK, triggering p53-independent apoptosis; it states further work is needed using siRNA/dead mutants to test whether PTP silencing rescues FAK dephosphorylation and apoptosis.
    Values are reported in the paper narrative at the 1.5 h time point.
    What’s measured vs what’s inferred (per the paper)
    Step Paper claims Evidence type in provided text Confidence* Key limitation / skeptical check
    Rb–E2F repression loss β†’ apoptosis dnE2F1 induction causes rapid apoptosis, described as p53-independent. Flow cytometry sub-G1 (<2N DNA content) accumulation within 24–48 h. Moderate (within-text method shown, but p53-independence readout details limited here) β€œp53-independent” is asserted; the provided text doesn’t show p53 status manipulation/verification in the same experimental section.
    E2F-1 β†’ PTP transcription PTPN1/PTPN11/PTPN12 mRNAs increase quickly after induction and then decline. qPCR time course (comparative Ct / 2^-ΔΔCt), with GAPDH unchanged; triplicate; t-test on 1.5 h. Strong mRNA increase β‰  protein activity; fold-change magnitudes are reported but full numeric series are not in provided excerpt.
    E2F-1 β†’ direct promoter binding E2F-1 binds promoters of the three PTP genes. ChIP with E2F-1 antibody; TRANSFAC-predicted sites; PCR primers on promoter regions; negative controls reported. Moderate ChIP enrichment metrics (fold-enrichment vs negative control) are not present in provided text; reliance on predicted β€œhighest match score” sites.
    PTPs → FAK dephosphorylation → apoptosis Proposed model: induced PTPs inactivate FAK and facilitate p53-independent apoptosis. Stated as plausible; authors describe planned functional rescue tests (siRNA / dead mutations). Low→Moderate No direct rescue/necessity experiment shown in the provided text; causality remains untested here.
    *Confidence is about the paper’s claim-to-evidence mapping based only on the provided full-text excerpt.
    Directed relationship graph (as stated)
    Nodes encode β€œdirection of claim” in the paper: dnE2F1 induction β†’ apoptosis; dnE2F1 derepression β†’ E2F-1 binding β†’ PTP transcription; PTPs β†’ proposed FAK inactivation (not shown as functional rescue in provided text).
    The directed relationships are based on the paper’s reported/applied logic.
    Skeptical critique (what’s strong, what’s missing)
    1) Strength: transcription + promoter binding are tightly coupled in time
    • The reported induction of PTP transcripts occurs rapidly (peaking around 1.5 h) during apoptosis program activation, and the same loci are reported as E2F-1-bound by ChIP, supporting an Rb–E2F-1 derepression β†’ transcriptional activation model.
    2) Core blind spot: causality between PTP induction and apoptosis execution
    • The paper advances a signaling hypothesis (PTPs facilitate FAK inactivation β†’ apoptosis), but in the provided excerpt it does not provide the decisive β€œnecessity” tests (e.g., PTP knockdown/dead mutant + rescue of FAK dephosphorylation + rescue of apoptosis).
    • Because only mRNA and ChIP are shown here, protein abundance and phosphatase activity remain unquantified in this excerpt; thus β€œPTP induction” is not yet equivalent to β€œPTP activation” in the same mechanistic chain.
    3) Interpretation risk: overreaching from promoter binding to functional network
    • ChIP demonstrates association with predicted promoter regions, but it does not establish that transcriptional induction of each PTP is required for apoptosis (especially if apoptosis can be driven by additional E2F targets or by parallel branches).
    What evidence would disprove or revise the main mechanistic storyline?
    • If PTPN1/PTPN11/PTPN12 knockdown (single and combined) does not rescue FAK dephosphorylation and/or does not rescue sub-G1 apoptosis in the dnE2F1 model, then the proposed β€œPTPs drive FAK inactivation β†’ apoptosis” causal link would be weakened.
    • If E2F-1 ChIP at these promoters is not accompanied by measurable protein activity changes (or if catalytically inactive mutants still show the same apoptosis phenotype), then β€œPTP induction” may be more epiphenomenal than causal.
    Apoptosis readout described (sub-G1 as time-limited outcome)
    The paper reports apoptosis progression as sub-G1 accumulation with most death occurring within the first 24–48 hours after induction.


    Feedback:    

    Updated: April 22, 2026

     BGPT Paper Review


    Study Novelty

    60%

    The mechanistic framing (Rb–E2F derepression driving apoptosis via PTPs/FAK axis) aligns with earlier work on PTP-1B in Rb–E2F-associated apoptosis, but this paper adds additional candidate PTPs (SHP-2 and PTP-PEST) with direct E2F-1 promoter binding and rapid transcriptional kinetics.


    Scientific Quality

    70%

    Strengths: coordinated qPCR time course plus E2F-1 ChIP at three PTP promoters; apoptosis kinetics via flow cytometry. Skeptical issues: the mechanistic β€œPTPs β†’ FAK dephosphorylation β†’ apoptosis” causal chain is proposed, with functional necessity experiments described as ongoing rather than shown in the provided text; mRNA induction and promoter binding do not by themselves prove protein phosphatase activation or required role. p53-independence is stated but not directly demonstrated within the provided excerpt.


    Study Generality

    60%

    The evidence is based on an in vitro dnE2F1 ER model in human U2OS cells, so it is moderately general for mechanistic E2F transcriptional regulation, but less general for tumor-relevant signaling networks without broader model validation in the provided text.


    Study Usefulness

    70%

    Useful for generating a concrete transcriptional target list (PTPN1/PTPN11/PTPN12) downstream of Rb–E2F-1 repression loss during apoptosis and for prioritizing follow-up functional tests of PTP necessity/FAK wiring.


    Study Reproducibility

    60%

    Methods are described (cell model, induction reagents, qPCR workflow, ChIP workflow, negative controls). However, the provided text does not include full numerical time-course tables (only fold-change highlights) and does not report data availability/accession numbers, which reduces practical reproducibility for quantitative reanalysis.


    Explanatory Depth

    70%

    Depth is moderate: it provides direct transcriptional regulation and promoter binding, but mechanistic pathway completion (protein activity and necessity linking to FAK and apoptosis execution) is not yet demonstrated in the excerpt.


    🎁 Authors: Collect 148 Free Science Tokens (β‰ˆ $14.8 USD)

    Claim My Author Tokens

    Use for 37 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $14.8 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    It extracts the paper’s reported fold-changes at 1.5 h for PTPN1/PTPN11/PTPN12 and renders a labeled comparative plot to support the transcriptional burst claim, without inventing missing time-point values.



     Hypothesis Graveyard


    If single PTP knockdown fully rescues FAK dephosphorylation and apoptosis, then the β€œin concert” model collapses toward a dominant mediator rather than a network of three cooperating PTPs.


    If catalytically dead versions of SHP-2 and PTP-PEST still allow apoptosis even when mRNA induction occurs normally, then phosphatase catalytic activity is not required for the apoptosis branch proposed here.

     Science Art


    Paper Review: SHP-2 and PTP-pest induction during Rb-E2F associated apoptosis Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending